Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Miconazole as an Inhibitor of Endothelium-Derived Hyperpolarizing Factor

NCT00004575 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00004575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Miconazole as an Inhibitor of Endothelium-Derived Hyperpolarizing Factor
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2000
Completion date
October 31, 2001
Enrollment
15
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy